<?xml version="1.0" encoding="UTF-8"?>
<svg height="759.857" width="4125.641" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(23,22,21);stroke-width:1.0;" d="M46.0 737.33 L567.0 737.33 "/>
  <g begin="text">
   <text y="749.857" x="504.762,511.845,517.542,522.231,527.694,531.24,536.649,540.492,546.099,551.463" svgx:width="0.79,0.63,0.52,0.61,0.39,0.6,0.43,0.62,0.6,0.39" style="fill:rgb(172,43,49);font-family:Verdana;font-size:9.0px;stroke:none;">Oncotarget</text>
  </g>
  <g begin="text">
   <text y="749.857" x="294.557,300.281,306.005,311.729" svgx:width="0.64,0.64,0.64,0.64" style="fill:rgb(23,22,21);font-family:Verdana;font-size:9.0px;stroke:none;">6543</text>
  </g>
  <g begin="text">
   <text y="748.857" x="46.0,53.362,60.724,67.789,71.065,76.528,82.225,86.914,92.377,95.923,101.332,105.175,110.782,116.146,119.692,122.968,127.657,133.12" svgx:width="0.82,0.82,0.82,0.36,0.61,0.63,0.52,0.61,0.39,0.6,0.43,0.62,0.6,0.39,0.36,0.52,0.61,0.97" style="fill:rgb(172,43,49);font-family:Verdana;font-size:9.0px;stroke:none;">www.oncotarget.com</text>
  </g>
  <g begin="text">
   <text y="53.823" x="51.0,58.832,66.664,74.496,77.384,82.88,88.576,93.28,98.776,102.424,107.768,111.744,117.336,122.648,126.296,129.184,133.888,139.384" svgx:width="0.98,0.98,0.98,0.36,0.69,0.71,0.59,0.69,0.46,0.67,0.5,0.7,0.66,0.46,0.36,0.59,0.69,1.06" style="fill:rgb(255,255,255);font-family:Verdana-Bold;font-size:8.0px;stroke:none;">www.oncotarget.com</text>
  </g>
  <g begin="text">
   <text y="53.823" x="147.859" svgx:width="0.34" style="fill:rgb(255,255,255);font-family:Verdana-Bold;font-size:8.0px;stroke:none;"> </text>
  </g>
  <g begin="text">
   <text y="53.823" x="272.947,281.447,288.567,294.447,301.317,305.877,312.557,317.527,324.517,331.157,335.717,339.327,342.747,349.857,356.967,364.077,371.187,374.797,378.217,385.857,392.727,396.147,399.757,403.177,410.287,417.397,421.007,424.427,429.857,438.327,445.197,448.807,452.227,459.337,466.447,471.877,475.487,478.907,485.897,492.887,496.907,500.327,507.437,514.547,521.657,528.767,533.567,540.677,547.787,554.897" svgx:width="0.85,0.71,0.59,0.69,0.46,0.67,0.5,0.7,0.66,0.46,0.36,0.34,0.71,0.71,0.71,0.71,0.36,0.34,0.76,0.69,0.34,0.36,0.34,0.71,0.71,0.36,0.34,0.54,0.85,0.69,0.36,0.34,0.71,0.71,0.54,0.36,0.34,0.7,0.7,0.4,0.34,0.71,0.71,0.71,0.71,0.48,0.71,0.71,0.71,0.71" style="fill:rgb(255,255,255);font-family:Verdana-Bold;font-size:10.0px;stroke:none;">Oncotarget, 2019, Vol. 10, (No. 61), pp: 6543-6545</text>
  </g>
  <g begin="text">
   <text y="96.205" x="58.2,67.748,77.1,84.058,93.844,103.14,109.524,114.312,124.28,134.066,138.952,148.738,158.706,168.324,176.626,186.426,196.394,205.746,212.13,221.482,229.784,239.08,247.382,252.282,257.07,267.038,271.938,280.17,289.522,299.49,307.722,317.032,323.99,329.618,334.518,342.82,352.788,362.574,372.36,379.318,388.614,396.916,405.218,410.006,419.624,429.592,434.506,444.124,450.032,454.918,469.73,479.082,489.05,498.164,503.064,512.164,521.46,528.418,536.72,546.688,554.99" svgx:width="0.68,0.67,0.5,0.7,0.66,0.46,0.34,0.71,0.7,0.34,0.7,0.71,0.69,0.59,0.7,0.71,0.67,0.46,0.67,0.59,0.66,0.59,0.34,0.34,0.71,0.34,0.59,0.67,0.71,0.59,0.66,0.5,0.4,0.34,0.59,0.71,0.7,0.7,0.5,0.66,0.59,0.59,0.34,0.69,0.71,0.34,0.69,0.42,0.34,1.06,0.67,0.71,0.65,0.34,0.65,0.66,0.5,0.59,0.71,0.59,0.34" style="fill:rgb(172,43,49);font-family:Verdana-Bold;font-size:14.0px;stroke:none;">Targeting phosphatases in cancer: suppression of many versus </text>
  </g>
  <g begin="text">
   <text y="113.005" x="58.2,64.584,74.552,83.848,88.636,97.988,107.774,112.562,121.914,128.298,133.086,142.704,152.672,157.46,167.078,172.986,177.774,187.392,197.36,206.656" svgx:width="0.46,0.71,0.66,0.34,0.67,0.7,0.34,0.67,0.46,0.34,0.69,0.71,0.34,0.69,0.42,0.34,0.69,0.71,0.66,0.34" style="fill:rgb(172,43,49);font-family:Verdana-Bold;font-size:14.0px;stroke:none;">the ablation of one </text>
  </g>
  <g begin="text">
   <text y="138.181" x="58.2,66.567,72.024,79.358,87.176,94.851,102.384,110.201,113.956,124.365,128.329,132.084,141.198,144.843,153.364,158.821,165.277,172.425,176.389,180.144,188.664,192.419,198.931,206.748,217.498,224.832,230.29,237.438,244.772,248.527,256.576,262.033,269.367,276.735,284.07,290.581,298.398,302.154,309.488,317.306,324.981,328.736,337.322,341.078,347.534,355.352,362.686,368.143,375.818,379.573,387.073,391.037,394.792,403.982,411.525,419.343,426.711,434.045,441.863,449.154" svgx:width="0.76,0.5,0.67,0.71,0.7,0.69,0.71,0.34,0.95,0.36,0.34,0.83,0.33,0.78,0.5,0.59,0.65,0.36,0.34,0.78,0.34,0.59,0.71,0.98,0.67,0.5,0.65,0.67,0.34,0.73,0.5,0.67,0.67,0.67,0.59,0.71,0.34,0.67,0.71,0.7,0.34,0.78,0.34,0.59,0.71,0.67,0.5,0.7,0.34,0.68,0.36,0.34,0.84,0.69,0.71,0.67,0.67,0.71,0.66,0.71" style="fill:rgb(23,22,21);font-family:Verdana-Bold;font-size:10.98px;stroke:none;">Brandon M. D’Arcy, Aishwarya Prakash and Richard E. Honkanen</text>
  </g>
  <g begin="text">
   <text y="178.934" x="82.0,88.232,95.036,98.432,103.532,108.632,113.732,116.232,139.538,142.935,148.035,151.431,154.828,159.928,163.325,171.26,175.789,178.625,183.725,188.825,191.66,196.76,199.596,204.696,209.225,212.621,217.15,221.679,224.514,229.614,234.143,237.54,242.64,246.036,250.565,255.094,258.491,263.591,268.691,273.791,278.891,281.726,285.123" svgx:width="0.61,0.67,0.33,0.5,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.33,0.5,0.33,0.78,0.44,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.44,0.33,0.44,0.44,0.28,0.5,0.44,0.33,0.5,0.33,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.28,0.33,0.33" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">LB-100 (3-(4-methylpiperazine-1-carbonyl)-</text>
  </g>
  <g begin="text">
   <text y="190.934" x="58.0,63.1,66.497,71.597,76.697,81.225,86.325,89.161,93.69,98.79,103.319,106.154,111.254,114.651,119.751,122.301,127.401,129.951,135.051,138.447,143.547,148.076,153.176,156.012,160.541,165.641,170.169,173.566,178.666,182.063,186.591,191.12,194.517,199.617,204.717,209.817,214.917,217.752,220.588,225.117,227.617,235.684,240.213,244.742,247.577,252.677,256.074,258.574,266.641,269.477,273.444,275.944,284.012,288.54" svgx:width="0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.25,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.33,0.5,0.33,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.44,0.44,0.28,0.5,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">7-oxabicyclo[2.2.1]heptane-2-carboxylic acid) is a </text>
  </g>
  <g begin="text">
   <text y="202.934" x="58.0,63.1,66.497,71.597,79.532,82.368,86.336,89.171,94.271,99.371,101.871,106.817,111.346,116.446,119.282,122.117,124.953,130.053,137.988,143.088,146.485,148.985,153.931,159.031,162.428,167.528,172.628,175.128,180.074,184.602,189.702,193.099,196.496,201.024,206.124,208.96,211.796,216.896,219.396,224.342,227.177,232.277,234.777,239.723,244.252,248.781,252.177,255.013,260.113,262.613,267.559,271.527,274.362,278.891,283.991,288.52" svgx:width="0.5,0.33,0.5,0.78,0.28,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.5,0.78,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.44,0.33,0.28,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">promising antitumor drug currently in early stage </text>
  </g>
  <g begin="text">
   <text y="214.934" x="58.0,62.529,65.364,68.19,73.29,76.125,80.654,85.183,88.019,90.519,91.364,94.2,98.729,102.696,105.532,108.368,113.468,118.568,121.118,123.618,124.463,130.695,137.499,140.895,145.995,151.095,156.195,158.695,159.541,164.641,169.17,173.138,175.638,176.483,181.012,186.112,188.948,194.048,196.883,201.983,207.083,209.919,214.448,216.948,217.793,222.322,226.851,229.686,232.522,237.622,240.458,243.293,248.393,250.893,251.739,256.268,261.368,265.896,268.732,273.832,277.8,280.635,283.135,283.981,288.51" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.67,0.33,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.55,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">clinical testing. LB-100 has cytotoxic activity against a </text>
  </g>
  <g begin="text">
   <text y="226.934" x="58.0,63.1,67.629,71.025,73.861,78.39,81.225,86.325,89.294,94.394,97.79,100.758,105.287,109.816,114.916,119.445,123.974,127.37,130.338,134.867,139.396,142.232,145.067,149.035,152.003,154.839,159.939,162.907,167.436,172.536,175.371,178.207,183.307,186.704,191.232,194.201,198.729,203.829,208.929,211.898,219.833,224.362,227.759,232.859,237.387,242.487,245.456,249.984,255.084,257.92,260.756,264.152,266.988,272.088,280.023,285.123,288.52" svgx:width="0.5,0.44,0.33,0.28,0.44,0.28,0.5,0.25,0.5,0.33,0.25,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.33,0.5,0.44,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.78,0.5,0.33,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">variety of cancer cells in culture and marked anti-tumor </text>
  </g>
  <g begin="text">
   <text y="238.934" x="58.0,62.491,66.982,69.784,72.596,77.653,80.465,83.277,88.334,90.984,93.796,98.854,101.504,105.995,111.052,113.864,121.733,126.224,129.036,131.686,139.556,144.613,149.67,154.161,156.973,160.908,163.558,168.615,171.984,174.634,177.446,182.503,190.372,195.43,198.798,201.448,206.505,210.996,216.054,220.545,223.357,228.414,233.472,241.341,245.832,250.889,253.701,256.23,258.88,264.504,269.561,274.052,277.987,282.478,285.128,288.496" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.28,0.78,0.44,0.28,0.25,0.78,0.5,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.78,0.5,0.33,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.25,0.56,0.5,0.44,0.39,0.44,0.25,0.33,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">activity in animal models of tumor development. Phase I </text>
  </g>
  <g begin="text">
   <text y="250.934" x="58.0,62.44,65.22,68.0,73.0,75.78,80.22,84.66,87.44,89.84,93.73,96.51,101.51,106.51,109.29,113.73,117.62,120.02,123.35,130.57,137.24,143.35,148.35,153.35,158.35,163.35,168.35,173.35,178.35,183.35,186.68,189.09,193.53,198.53,203.53,207.97,210.75,215.75,220.75,225.19,230.19,232.59,235.37,240.37,244.81,247.59,249.99,252.77,257.77,262.21,264.61,268.5,272.94,276.27,280.71,283.49,288.49" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">clinical studies (NCT01837667) concluded that the safety </text>
  </g>
  <g begin="text">
   <text y="262.934" x="58.0,63.1,67.629,71.025,75.554,83.49,88.019,90.854,95.383,98.78,102.747,105.247,107.154,112.254,115.65,118.15,120.057,126.289,133.092,136.489,141.589,146.689,151.789,154.289,156.195,160.163,165.263,170.363,175.463,180.563,183.96,186.795,189.295,191.202,195.731,200.831,205.931,208.766,211.602,216.702,221.802,226.331,231.431,233.931,235.837,240.937,245.466,250.566,255.095,257.93,263.03,268.13,276.066,280.595,285.695,288.53" svgx:width="0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.67,0.33,0.5,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">parameters of LB-100 support continued development </text>
  </g>
  <g begin="text">
   <text y="274.934" x="58.0,61.343,66.363,69.706,72.216,74.846,80.428,85.447,89.905,93.81,98.267,100.898,104.241,109.26,112.051,115.394,118.737,121.367,124.158,127.501,130.292,134.75,137.541,141.446,144.076,147.419,154.667,161.364,167.498,172.517,177.537,182.556,187.576,192.596,197.615,202.635,205.265,209.722,214.742,219.762,222.392,229.64,236.336,242.47,247.49,252.509,257.529,262.549,267.568,272.588,277.607,282.627,285.97,288.48" svgx:width="0.33,0.5,0.33,0.25,0.25,0.56,0.5,0.44,0.39,0.44,0.25,0.33,0.5,0.28,0.33,0.33,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">[1]. Phase Ib/II trials (NCT0388662 and NCT03027388), </text>
  </g>
  <g begin="text">
   <text y="286.934" x="58.0,65.076,69.976,72.7,77.051,81.951,84.215,91.291,94.015,96.739,99.464,101.728,106.079,109.891,113.703,118.054,121.867,125.679,127.943,130.667,135.567,139.918,142.182,145.994,150.345,153.609,157.96,160.684,165.584,167.848,172.199,177.099,181.999,184.263,188.614,191.878,197.327,201.678,206.029,210.38,215.28,217.544,222.444,225.707,227.971,233.959,240.495,243.759,248.659,253.559,258.459,260.723,265.074,269.974,274.325,277.049,281.949,285.762,288.486" svgx:width="0.72,0.5,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.28,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.56,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.61,0.67,0.33,0.5,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">which will assess the safety and efficacy of LB-100 against </text>
  </g>
  <g begin="text">
   <text y="298.934" x="58.0,65.936,71.036,75.564,78.4,83.5,88.6,93.7,97.668,102.768,105.603,110.132,114.1,116.936,119.771,124.3,127.258,131.226,136.326,141.426,146.526,149.922,155.022,162.958,167.487,171.455,174.413,178.941,184.041,189.141,192.099,195.496,200.025,204.554,209.654,213.05,216.447,220.976,226.076,228.911,231.869,236.969,239.805,242.64,247.74,252.84,255.676,260.205,264.173,267.008,272.108,280.044,284.573,288.54" svgx:width="0.78,0.5,0.44,0.28,0.5,0.5,0.5,0.39,0.5,0.28,0.44,0.39,0.28,0.28,0.44,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.5,0.28,0.28,0.5,0.5,0.28,0.44,0.39,0.28,0.5,0.78,0.44,0.39,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">myelodysplastic syndromes and recurrent glioblastomas </text>
  </g>
  <g begin="text">
   <text y="310.934" x="58.0,61.397,65.925,69.893,72.729,76.125,81.225,85.754,90.854,93.69,98.79,106.725,111.254,113.804,116.304,118.547,123.647,126.483,129.318,134.418,139.518,142.354,146.883,150.851,153.686,158.786,166.722,171.251,173.751,175.994,183.929,189.029,191.865,194.7,197.536,200.933,206.033,209.429,217.365,221.894,224.444,226.944,229.187,233.715,238.815,243.915,246.415,248.658,253.758,256.594,261.123,266.223,269.058,271.558,273.801,278.33,282.859,285.695,288.53" svgx:width="0.33,0.44,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.5,0.78,0.44,0.25,0.25,0.55,0.5,0.28,0.28,0.5,0.5,0.28,0.44,0.39,0.28,0.5,0.78,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.33,0.78,0.44,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">(astrocytoma, glioblastoma multiforme, and giant cell </text>
  </g>
  <g begin="text">
   <text y="322.934" x="58.0,63.0,65.78,68.56,73.56,78.56,81.34,85.78,89.67,92.45,97.45,105.23,109.67,113.0,115.5,118.83,123.27,127.16,132.16,136.6,141.04,143.82,146.6,151.6,156.04,158.82,163.15,165.65,168.15,172.59,175.92,180.36,182.86,187.86,192.86,197.86,202.86,205.64,210.64,215.64" svgx:width="0.5,0.28,0.28,0.5,0.5,0.28,0.44,0.39,0.28,0.5,0.78,0.44,0.33,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">glioblastoma) respectively, are ongoing.</text>
  </g>
  <g begin="text">
   <text y="334.934" x="82.0,87.992,92.347,95.613,98.339,103.243,105.567,108.833,113.188,118.092,122.995,126.261,128.988,132.803,135.127,138.393,142.748,147.651,152.006,156.36,159.087,163.441,168.345,170.67,173.396,178.3,182.654,185.381,187.705,193.698,200.239,203.505,208.409,213.313,218.216,220.541,224.895,229.25,231.976,235.791,238.116,242.47,246.285,248.61,252.964,255.289,259.643,263.998,266.724,271.079,273.805,278.709,281.435,284.162,288.516" svgx:width="0.61,0.44,0.33,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.39,0.25,0.33,0.44,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.61,0.67,0.33,0.5,0.5,0.5,0.25,0.44,0.44,0.28,0.39,0.25,0.44,0.39,0.25,0.44,0.25,0.44,0.44,0.28,0.44,0.28,0.5,0.28,0.28,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">Early reports revealed that LB-100 acts as a catalytic </text>
  </g>
  <g begin="text">
   <text y="346.934" x="58.0,60.836,65.936,71.036,73.871,78.971,81.807,84.642,89.742,93.139,95.639,97.647,102.747,106.144,108.644,110.652,114.62,119.149,122.546,125.381,130.481,135.01,137.846,140.681,145.781,149.178,153.707,158.807,163.907,166.742,171.842,176.371,178.871,180.879,185.979,191.079,196.179,200.147,205.247,210.347,214.876,217.712,222.24,226.208,230.737,233.237,235.245,240.345,247.149,249.649,251.657,255.054,260.725,266.396,271.496,278.861,285.664,288.5" svgx:width="0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.44,0.33,0.28,0.5,0.44,0.28,0.28,0.5,0.33,0.44,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.28,0.44,0.39,0.44,0.25,0.55,0.5,0.72,0.25,0.55,0.33,0.56,0.56,0.5,0.72,0.67,0.28,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">inhibitor of serine/threonine phosphatase 2A (PP2AC: </text>
  </g>
  <g begin="text">
   <text y="358.934" x="58.0,62.529,67.629,72.158,77.258,82.358,86.886,91.986,95.057,100.157,105.257" svgx:width="0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">encoded by </text>
  </g>
  <g begin="text">
   <text y="358.934" x="108.313,114.546,120.778,127.01,132.11,138.913,145.146,147.981,154.213,160.445,166.678,171.778,178.581" svgx:width="0.61,0.61,0.61,0.5,0.67,0.61,0.28,0.61,0.61,0.61,0.5,0.67,0.61" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-ItalicMT;font-size:10.0px;stroke:none;">PPP2CA/PPP2CB</text>
  </g>
  <g begin="text">
   <text y="358.934" x="184.798,188.195,190.745,193.815,202.883,207.983,211.38,215.908,218.979,222.375,226.904,231.433,235.962,241.062,243.897,246.733,251.17,253.72,256.79,263.022,269.826,273.222,278.322,283.422,288.522" svgx:width="0.33,0.25,0.25,0.89,0.5,0.33,0.44,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.61,0.67,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">). More recently, LB-100 </text>
  </g>
  <g begin="text">
   <text y="370.934" x="58.0,65.364,69.893,73.861,76.87,80.838,85.938,91.038,98.402,103.502,106.511,109.347,114.447,117.466,121.995,124.83,128.798,133.898,136.917,139.753,144.282,147.495,152.595,157.124,159.959,162.978,168.65,174.321,179.992,185.092,191.895,194.445,197.465,200.3,205.4,210.5,213.336,218.436,221.271,224.107,226.943,232.043,237.143,240.162,245.833,251.504,256.604,263.969,270.772,273.791,278.32,283.42,288.52" svgx:width="0.72,0.44,0.39,0.25,0.39,0.5,0.5,0.72,0.5,0.25,0.28,0.5,0.25,0.44,0.28,0.39,0.5,0.25,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.56,0.56,0.56,0.5,0.67,0.25,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.56,0.56,0.5,0.72,0.67,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">was shown to also target PPP5C, inhibiting PP2AC and </text>
  </g>
  <g begin="text">
   <text y="178.934" x="324.5,330.171,335.842,341.514,346.614,353.417,356.64,364.005,366.84,369.676,374.776,377.999,381.967,384.802,392.738,395.574,398.409,402.938,406.335,409.558,414.658,419.758,422.594,427.122,432.222,436.751,441.851,445.074,448.471,451.868" svgx:width="0.56,0.56,0.56,0.5,0.67,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.5,0.5,0.28,0.44,0.5,0.44,0.5,0.25,0.33,0.33,0.67" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">PPP5C with similar potency (IC</text>
  </g>
  <g begin="text">
   <text y="182.264" x="458.656,461.629,464.603" svgx:width="0.5,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:5.83px;stroke:none;">50 </text>
  </g>
  <g begin="text">
   <text y="178.934" x="466.481,472.234,475.457,480.557,483.107,488.207,491.43,495.959,501.059,506.159,509.382,514.482,517.032,522.132,525.355,530.822,539.89,543.113,546.51,551.61,555.007" svgx:width="0.56,0.25,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.54,0.89,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">= 0.4 and 1.8 μM for </text>
  </g>
  <g begin="text">
   <text y="190.934" x="324.5,330.171,335.842,340.942,348.307,355.11,357.61,358.384,362.913,368.013,373.113,375.613,376.387,382.059,387.73,393.401,398.501,405.304,407.854,410.354,411.129,414.525,419.054,423.022,428.122,432.651,437.18,440.015,442.851,447.951,452.48,455.315,460.415,463.812,466.312,467.086,470.483,475.583,478.979,481.529,484.62,490.138,495.238,497.738,498.512,503.612,508.141,510.977,515.505,518.902,526.838,529.673,534.773,539.302,541.802,542.576,545.412,550.512,555.04" svgx:width="0.56,0.56,0.5,0.72,0.67,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.56,0.56,0.5,0.67,0.25,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.33,0.25,0.55,0.33,0.5,0.33,0.25,0.25,0.61,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">PP2AC and PPP5C, respectively) [2]. To determine the </text>
  </g>
  <g begin="text">
   <text y="202.934" x="324.5,332.436,337.536,340.371,344.9,349.429,354.529,357.364,361.893,365.29,367.79,369.533,374.633,379.162,383.13,385.965,389.933,392.433,394.176,397.573,402.673,406.069,408.569,410.313,414.841,419.37,422.206,426.735,429.57,434.67,437.506,440.342,444.87,447.37,449.114,451.949,457.049,462.149,464.985,470.085,472.92,475.756,478.592,483.692,488.792,491.342,493.842,495.585,502.949,507.478,509.978,511.721,515.689,520.789,523.625,528.724,533.253,538.353,540.853,542.596,545.432,550.532,555.061" svgx:width="0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.5,0.44,0.39,0.28,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.44,0.28,0.44,0.28,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.72,0.44,0.25,0.55,0.39,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">molecular basis for catalytic inhibition, we solved the </text>
  </g>
  <g begin="text">
   <text y="214.934" x="324.5,329.489,332.262,337.251,342.24,345.562,348.885,353.315,357.196,362.185,364.958,369.947,372.721,375.495,380.483,385.472,387.837,392.267,395.589,400.578,404.459,407.233,411.663,414.436,416.801,420.682,423.456,426.778,431.767,436.197,438.971,443.959,447.282,451.712,454.077,459.065,462.388,464.752,470.3,475.847,481.395,486.383,493.038,495.403,498.177,503.165,505.53,508.304,513.292,517.722,520.087,525.076,528.398,532.828,536.709,541.139,546.128,550.558,554.988" svgx:width="0.5,0.28,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.25,0.39,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.56,0.56,0.56,0.5,0.67,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">high-resolution crystal structure of PPP5C in the presence </text>
  </g>
  <g begin="text">
   <text y="226.934" x="324.5,329.5,332.83,335.44,341.55,348.22,351.55,356.55,361.55,366.55,369.16,373.6,376.38,378.99,383.43,386.04,389.37,393.81,397.7,402.7,405.48,410.48,413.26,416.04,421.04,426.04,428.65,433.65,436.98,439.59,444.59,447.09,452.09,457.09,459.7,466.92,469.42,472.03,479.25,484.25,487.03,491.47,496.47,499.08,502.41,506.85,511.85,516.29,520.73,523.51,527.95,532.95,535.56,540.0,542.78,547.22,551.66,554.99" svgx:width="0.5,0.33,0.25,0.61,0.67,0.33,0.5,0.5,0.5,0.25,0.44,0.28,0.25,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.5,0.25,0.72,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.33,0.44,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.44,0.44,0.33,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">of LB-100 at a resolution of 1.65 Å, which revealed clear </text>
  </g>
  <g begin="text">
   <text y="238.934" x="324.5,329.029,331.864,336.383,340.912,343.747,347.144,352.244,357.344,360.373,365.473,370.002,375.102,379.07,381.906,384.741,389.841,392.871,396.267,401.367,404.764,407.793,410.629,415.729,420.258,423.287,428.387,431.784,436.884,441.984,446.513,451.613,454.448,458.977,464.077,468.606,471.441,476.541,479.938,485.038,487.588,492.688,495.238,500.338,503.735,508.835,513.363,518.463,521.299,525.828,530.928,535.457,538.853,543.953,546.503,551.603" svgx:width="0.44,0.28,0.44,0.44,0.28,0.33,0.5,0.5,0.25,0.5,0.44,0.5,0.39,0.28,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.25,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.33,0.5,0.25,0.5,0.33" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">electron density for the 7-oxabicyclo[2.2.1]heptane-2,3-</text>
  </g>
  <g begin="text">
   <text y="250.934" x="324.5,329.6,332.436,336.964,341.493,344.89,349.99,355.09,360.19,365.29,368.125,370.625,372.471,380.406,385.506,388.342,392.871,395.706,400.143,402.693,405.193,407.039,414.403,417.239,420.074,425.174,427.674,429.519,432.355,437.455,441.984,444.484,446.329,451.429,453.979,459.079,462.476,467.576,470.411,474.94,479.469,482.865,487.965,493.065,498.165,503.265,506.101,508.601,510.446,515.546,518.943,521.443,523.288,529.52,536.324,539.72,544.82,549.92,555.02" svgx:width="0.5,0.28,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.78,0.5,0.28,0.44,0.28,0.5,0.25,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.67,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">dicarbonyl moiety, with the 2,3-dicarbonyl of LB-100 </text>
  </g>
  <g begin="text">
   <text y="262.934" x="324.5,329.029,334.129,339.229,342.625,347.725,350.561,355.661,360.19,363.025,365.861,370.961,376.061,378.561,380.223,387.587,390.423,393.258,398.358,400.858,402.51,407.61,412.71,415.545,420.645,423.145,424.797,429.326,433.854,436.69,441.219,444.054,449.154,451.99,454.826,459.354,461.854,463.506,471.441,475.97,478.806,483.335,486.17,490.138,492.638,494.289,497.686,506.754,511.854,514.354,516.005,520.534,525.634,530.734,533.234,534.885,543.953,549.053,552.45,555.0" svgx:width="0.44,0.5,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.44,0.28,0.44,0.28,0.5,0.28,0.28,0.44,0.25,0.55,0.78,0.44,0.28,0.44,0.28,0.39,0.25,0.55,0.33,0.89,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.5,0.33,0.25,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">coordinating with both catalytic metals (M1 and M2). </text>
  </g>
  <g begin="text">
   <text y="274.934" x="324.5,327.897,332.997,335.497,336.903,342.003,345.4,350.5,355.029,358.425,360.925,362.332,365.167,370.267,372.767,374.174,378.703,383.232,387.76,392.86,400.796,408.732,413.832,418.932,423.46,426.296,430.825,433.325,434.731,437.567,442.667,447.196,449.696,451.102,453.938,459.038,464.138,466.974,472.074,474.909,477.745,482.845,485.834,488.384,490.884,492.29,495.126,500.226,504.755,507.255,508.661,512.629,515.464,520.564,525.093,527.593,529.0,533.529,538.629,543.157,545.993,551.093,555.061" svgx:width="0.33,0.5,0.25,0.55,0.5,0.33,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.44,0.44,0.5,0.78,0.78,0.5,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">In order to accommodate the inhibitor, the side chains </text>
  </g>
  <g begin="text">
   <text y="286.934" x="324.5,329.6,332.997,335.73,343.095,346.308,351.408,356.508,361.608,366.708,369.208,370.012,374.541,379.641,384.741,387.852,393.371,398.471,401.867,406.967,412.067,417.167,419.667,420.472,425.001,430.101,435.201,440.301,443.136,445.636,446.441,450.97,453.806,456.641,461.17,464.567,469.667,474.195,477.031,481.56,484.06,484.865,489.393,494.493,499.594,502.99,508.09,511.487,519.422,523.951,526.787,529.622,534.722,539.822,543.79,546.29,547.095,549.93,555.03" svgx:width="0.5,0.33,0.25,0.72,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.61,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.25,0.55,0.44,0.28,0.28,0.44,0.33,0.5,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">of Arg275 and Tyr451 adopt alternate conformations in </text>
  </g>
  <g begin="text">
   <text y="298.934" x="324.5,327.897,332.425,335.261,339.79,342.625,345.461,350.561,355.661,358.578,361.414,366.514,369.431,372.267,377.367,381.895,384.813,389.341,393.87,396.706,399.542,404.642,409.17,412.088,416.055,418.891,421.727,426.255,429.173,437.108,441.637,444.473,449.001,451.837,455.805,458.355,461.272,465.801,470.901,476.001,478.918,481.754,486.854,491.382,494.3,501.664,506.764,509.681,514.781,518.178,521.013,526.113,531.213,535.742,540.842,545.371,549.9,555.0" svgx:width="0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.39,0.28,0.28,0.44,0.25,0.78,0.44,0.28,0.44,0.28,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.5,0.25,0.5,0.33,0.28,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">relation to the active site metals, and the O7 bridgehead </text>
  </g>
  <g begin="text">
   <text y="310.934" x="324.5,329.6,334.7,339.8,344.9,349.429,354.529,357.029,361.465,364.861,369.39,374.49,377.326,381.855,386.383,390.912,394.88,397.38,401.816,404.652,409.752,414.281,416.781,421.217,428.581,433.11,435.945,440.474,443.871,446.371,450.807,458.742,463.842,466.678,471.207,475.736,480.836,483.671,488.2,490.75,493.25,497.676,505.04,510.14,512.976,517.505,522.605,525.105,529.541,536.905,542.005,547.105,549.94,555.04" svgx:width="0.5,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.5,0.28,0.44,0.44,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.44,0.28,0.44,0.33,0.25,0.55,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.72,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">oxygen replaces the water molecule, which would </text>
  </g>
  <g begin="text">
   <text y="322.934" x="324.5,329.6,332.436,337.536,342.064,345.461,352.825,355.661,359.629,364.158,366.658,368.462,372.991,378.091,383.191,386.587,391.688,394.523,399.623,404.152,406.988,411.516,414.016,415.821,423.185,426.021,428.856,433.956,436.456,438.261,446.196,450.725,453.561,458.09,460.925,463.425,465.23,468.065,473.165,478.265,480.815,483.315,485.12,494.187,499.287,501.837,504.337,505.958,512.19,517.29,520.126,524.094,526.594,528.398,532.927,537.456,542.556,546.523,551.052,555.02" svgx:width="0.5,0.28,0.5,0.44,0.33,0.72,0.28,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.28,0.25,0.55,0.28,0.5,0.5,0.25,0.25,0.55,0.89,0.5,0.25,0.25,0.55,0.61,0.5,0.28,0.39,0.25,0.55,0.44,0.44,0.5,0.39,0.44,0.39,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">otherwise coordinate with metal ion, M2. This causes </text>
  </g>
  <g begin="text">
   <text y="334.934" x="324.5,327.288,332.303,336.756,339.383,342.171,347.186,352.2,354.988,360.003,362.791,365.579,370.594,373.933,376.561,379.349,384.364,386.991,392.006,396.459,399.086,401.875,404.663,409.677,414.692,417.48,420.268,425.282,427.91,432.363,437.378,442.392,445.732,450.746,453.534,458.549,463.002,465.79,470.243,475.257,477.885,485.126,487.914,490.702,495.717,498.505,503.519,506.147,508.935,513.95,518.403,521.03,525.483,529.936,532.724,537.177,539.965,544.98,547.768,550.556,555.009" svgx:width="0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.28,0.28,0.5,0.5,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.44,0.28,0.5,0.28,0.28,0.44,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">the inhibitor to be tightly coordinated within the catalytic </text>
  </g>
  <g begin="text">
   <text y="346.934" x="324.5,329.6,334.7,339.229,344.329,348.858,351.693,354.243,357.273,362.373,365.208,370.308,374.837,379.937,382.773,387.873,392.973,396.002,399.97,405.07,410.17,414.138,416.973,420.37,424.899,427.734,432.263,435.292,439.821,444.35,448.879,453.408,457.376,461.343,464.373,467.208,472.308,475.338,478.173,483.273,487.802,490.832,495.36,499.889,502.725,507.254,510.089,515.189,518.025,520.86,525.389,528.419,536.354,540.883,543.719,548.247,551.083,555.051" svgx:width="0.5,0.5,0.44,0.5,0.44,0.28,0.25,0.25,0.5,0.28,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.39,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.25,0.44,0.44,0.44,0.44,0.39,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.44,0.28,0.5,0.28,0.28,0.44,0.25,0.78,0.44,0.28,0.44,0.28,0.39,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">pocket, blocking substrate access to the catalytic metals </text>
  </g>
  <g begin="text">
   <text y="358.934" x="324.5,327.856,333.458,336.26,341.298,346.336,349.692,354.166,356.806,361.845,365.2,367.719,370.359,377.635,382.673,389.949,394.423,399.461,403.935,406.888,409.407,412.047,414.849,419.887,422.527,427.565,432.604,435.959,438.6,443.638,446.439,451.478,456.516,459.872,463.227,467.701,471.621,476.66,479.461,484.499,487.301,490.102,495.14,500.179,502.819,506.739,509.54,512.896,517.934,522.408,525.21,530.248,533.604,538.078,540.718,544.073,549.112,552.467,554.987" svgx:width="0.33,0.56,0.28,0.5,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.25,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.28,0.5,0.25,0.5,0.5,0.33,0.25,0.5,0.28,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.39,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.25,0.33,0.5,0.33,0.25,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">(Figure 1). However, in our high-resolution structure [2], </text>
  </g>
  <g begin="text">
   <text y="370.934" x="324.5,327.28,332.28,336.72,340.05,344.49,347.07,349.85,353.74,356.32,361.32,366.32,368.9,373.9,378.34,383.34,387.23,390.01,392.79,397.79,400.37,403.7,408.7,412.03,414.61,417.39,422.39,426.83,429.41,434.41,437.74,441.07,446.07,449.4,457.18,461.62,464.4,469.4,474.4,477.18,480.51,485.51,488.84,493.84,496.62,501.62,506.06,509.39,513.83,518.27,521.05,526.05,530.49,533.82,536.39,539.72,542.5,547.5,552.5,555.0" svgx:width="0.28,0.5,0.44,0.33,0.44,0.25,0.28,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.5,0.39,0.28,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.33,0.5,0.33,0.78,0.44,0.28,0.5,0.5,0.28,0.33,0.5,0.33,0.5,0.28,0.5,0.44,0.33,0.44,0.44,0.28,0.5,0.44,0.33,0.25,0.33,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;">there is no density for the 3-(4-methyl-1-piperazine) ring, </text>
  </g>
  <g begin="text">
   <text y="77.448" x="458.594,461.334,464.074,466.814,469.554,472.294,475.034,477.774,480.514,483.254,485.994,488.734,491.474,494.214,496.954,499.694,502.434,505.174,507.914,514.744,521.734,525.154,529.714,536.583,541.553,544.973,551.653" svgx:width="0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.68,0.7,0.34,0.46,0.69,0.5,0.34,0.67,0.34" style="fill:rgb(23,22,21);font-family:Verdana-Bold;font-size:10.0px;stroke:none;"> Editorial</text>
  </g>
  <rect style="stroke:blue;stroke-width:0.3;" x="115.641" y="410.401" height="243.253" width="381.439" title="1"/>
  <text y="410.401" class="image" id="image.1.1" width="381" height="243" x="115.641">image.1.1.116_497.410_654</text>
  <rect style="stroke:blue;stroke-width:0.3;" x="115.641" y="410.401" height="243.253" width="381.439" title="1"/>
  <text y="410.401" class="image" id="image.1.2" width="381" height="243" x="115.641">image.1.2.116_497.410_654</text>
  <g begin="text">
   <text y="659.855" x="58.1,63.599,66.101,70.601,75.605,79.439,83.435,86.171,90.671,93.668,96.404,101.408,106.412,111.416,115.412,119.408,121.91,129.407,134.411,138.911,142.412,146.408,151.412,154.148,157.649,162.653,166.649,169.646,174.146,178.142,182.138,184.874,188.708,192.704,197.708,201.542,205.538,209.039,213.035,218.039,221.036,225.536,228.533,231.035,235.535,240.539,243.275,247.775,250.772,253.508,259.007,264.506,269.006,275.504,282.002,284.738,289.238,294.242,299.246,301.982,307.481,312.98,318.479,322.979,329.477,332.213,338.711,341.213,344.21,349.214,351.95,357.953,363.956,366.953,371.453,375.953,380.453,388.949,391.451,395.447,400.451,405.455,409.955,412.952,417.956,422.456,424.958,427.46,430.196,435.2,439.7,443.201,445.703,448.7,451.202,455.702,460.706,464.702,469.706,472.442,477.446,480.947,483.449,488.453,492.953,495.689,498.686,503.69,507.686,510.422,514.418,518.918,523.418,527.414,532.418,534.92,539.924,544.424,547.421,551.417,554.918" svgx:width="0.61,0.28,0.5,0.56,0.44,0.44,0.25,0.5,0.33,0.25,0.56,0.56,0.56,0.44,0.44,0.28,0.83,0.56,0.5,0.39,0.44,0.56,0.25,0.39,0.56,0.44,0.33,0.5,0.44,0.44,0.25,0.44,0.44,0.56,0.44,0.44,0.39,0.44,0.56,0.33,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.61,0.61,0.5,0.72,0.72,0.25,0.5,0.56,0.56,0.25,0.61,0.61,0.61,0.5,0.72,0.25,0.72,0.28,0.33,0.56,0.25,0.67,0.67,0.33,0.5,0.5,0.5,0.94,0.28,0.44,0.56,0.56,0.5,0.33,0.56,0.5,0.28,0.28,0.25,0.56,0.5,0.39,0.28,0.33,0.28,0.5,0.56,0.44,0.56,0.25,0.56,0.39,0.28,0.56,0.5,0.25,0.33,0.56,0.44,0.25,0.44,0.5,0.5,0.44,0.56,0.28,0.56,0.5,0.33,0.44,0.39,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Figure 1: Superimposed surface representation of PP2AC and PPP5C with LB-100M/endothall positioned using the coordinates </text>
  </g>
  <g begin="text">
   <text y="670.655" x="58.1,61.097,64.931,69.431,76.928,78.242,81.239,86.243,90.239,91.553,97.052,102.551,108.05,112.55,119.048,122.045,128.048,134.051,137.048,141.548,146.048,150.548,151.862,155.858,160.358,167.855,172.859,175.361,179.357,183.857" svgx:width="0.33,0.44,0.5,0.83,0.25,0.33,0.56,0.44,0.25,0.61,0.61,0.61,0.5,0.72,0.33,0.67,0.67,0.33,0.5,0.5,0.5,0.25,0.44,0.5,0.83,0.56,0.28,0.44,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">from the PPP5C:LB-100 complex.</text>
  </g>
  <g begin="text">
   <text y="670.655" x="186.094,187.408,193.411,197.408,201.908,204.41,205.714,208.711,212.707,216.208,218.71,223.21,227.71,231.706,235.208,236.521,239.023,243.523,247.52,250.021,251.326,255.322,258.319,262.315,263.62,267.616,272.116,276.616,280.117,284.113,287.111,291.611,295.607,300.107,301.411,305.911,309.908,312.41,318.908,322.904,326.9,331.4,332.704,337.708,342.712,347.212,353.71,359.713,361.027,365.023,369.523,374.023,375.337,380.341,385.345,390.349,394.849,400.852,403.354,404.668,409.168,411.67,416.17,420.166,422.668,423.973,426.97,430.966,434.467,436.97,441.47,445.97,449.966,453.467,454.781,461.279,463.781,466.283,470.783,472.097,475.598,478.1,485.102,487.604,490.106,494.102,497.099,498.404,502.904,507.404,511.904,515.405,517.907,522.407,526.403,530.903,534.899,541.901,544.403,548.399,552.395,554.897" svgx:width="0.25,0.67,0.44,0.5,0.28,0.25,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.39,0.25,0.28,0.5,0.44,0.28,0.25,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.56,0.56,0.5,0.72,0.67,0.25,0.44,0.5,0.5,0.25,0.56,0.56,0.56,0.5,0.67,0.28,0.25,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.5,0.5,0.5,0.39,0.28,0.5,0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> Red: residues that are conserved between PP2AC and PPP5C; blue: residues with similar physiochemical </text>
  </g>
  <g begin="text">
   <text y="681.455" x="58.1,62.6,65.597,70.097,74.597,78.593,81.59,84.092,86.594,90.59,94.091,96.593,98.843,99.689,104.189,108.185,110.687,113.189,117.689,124.187,126.689,128.939,129.785,132.782,136.778,140.279,142.781,147.281,151.781,155.777,159.278,161.528,162.374,168.872,171.374,173.876,178.376,180.626,181.472,185.972,188.474,191.309,194.306,198.302,201.299,205.295,209.795,212.297,214.547,215.393,219.893,224.393,228.893,232.394,234.896,239.396,243.392,247.892,251.888,258.89,261.392,265.388,269.384,271.886,274.136,274.973,279.473,282.47,286.97,291.47,295.466,298.463,300.965,303.467,307.463,310.964,313.466,315.716,316.562,321.062,324.059,328.055,332.051,336.551,339.053,341.303,342.149,346.145,350.645,355.145,358.142,362.642,365.639,372.641,376.637,379.139,381.641,386.141,390.641,392.891,393.737,398.237,401.234,403.484,404.33,407.327,411.323,414.824,417.326,421.826,426.326,430.322,433.823,436.073,436.919,441.419,445.919,448.421,452.921,457.421,461.417,463.667,464.513,467.015,471.515,473.765,474.611,477.113,481.613,485.609,487.859,488.705,492.701,495.698,500.198,503.699,506.201,510.197,512.699,514.949,515.795,520.295,524.291,528.287,532.787,535.289,539.789,544.289,546.539,547.385,551.885,554.882" svgx:width="0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.72,0.28,0.25,0.55,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.5,0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.28,0.25,0.55,0.5,0.33,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.39,0.25,0.55,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.25,0.55,0.5,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">properties; yellow: residues with different physiochemical properties; green: conformation of residues unique to the crystal packing of </text>
  </g>
  <g begin="text">
   <text y="692.255" x="58.1,63.104,68.108,73.112,77.612,83.615,86.117,88.457,92.957,95.954,99.95,104.45,108.95,112.946,115.448,117.779,121.775,126.275,130.775,133.772,138.272,141.269,148.271,152.267,154.769,157.271,161.771,166.271,168.602,173.102,176.099,178.43,181.427,185.423,188.924,191.426,195.926,200.426,204.422,207.923,210.254,214.754,219.254,221.756,226.256,230.756,234.752,237.083,239.585,244.085,246.416,248.918,253.418,257.414,259.745,263.741,266.738,271.238,274.739,277.241,281.237,283.739,286.07,290.57,294.566,298.562,303.062,305.564,310.064,314.564,316.895,321.395,324.392,326.723,331.727,336.731,341.231,347.729,353.732,356.234,358.574,362.57,367.07,371.066,375.566,378.068,380.399,385.403,390.407,395.411,399.911,405.914,408.254,415.256,419.252,421.754,425.75,428.252,430.574,433.076,437.576,442.076,445.577,448.079,450.41,457.412,461.408,465.908,469.904,474.404,476.906,480.902,483.404,485.726,490.73,495.734,500.234,506.732,512.735,515.075,522.077,526.073,528.575,532.571,535.073,537.395,539.897,544.397,548.897,552.398,554.9" svgx:width="0.56,0.56,0.56,0.5,0.67,0.28,0.25,0.5,0.33,0.44,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.25,0.5,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.56,0.56,0.5,0.72,0.67,0.28,0.25,0.44,0.5,0.44,0.5,0.28,0.25,0.56,0.56,0.56,0.5,0.67,0.25,0.78,0.44,0.28,0.44,0.28,0.25,0.28,0.5,0.5,0.39,0.28,0.25,0.78,0.44,0.5,0.44,0.5,0.28,0.44,0.28,0.25,0.56,0.56,0.5,0.72,0.67,0.25,0.78,0.44,0.28,0.44,0.28,0.25,0.28,0.5,0.5,0.39,0.28,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PPP5C; orange: conformation of residues unique to the crystal packing of PP2AC; cyan: PPP5C metal ions; magenta: PP2AC metal ions; </text>
  </g>
  <g begin="text">
   <text y="703.055" x="58.1,62.096,66.596,71.096,73.346,74.435,78.935,81.932,85.928,90.428,92.93,95.18,96.269,98.771,103.271,107.267,109.517,110.597,115.097,118.094,122.594,127.094,131.09,135.59,138.092,142.088,146.588,150.584,153.086,157.586,160.583,165.083,167.333,171.833,174.083,178.583,181.58,186.08,190.076,194.576,197.078,201.074,205.574,209.57,212.567,217.067,219.317,223.817,226.814,231.314,233.816,237.812,241.808,244.805,249.305,253.805,258.305,262.805,265.307,267.557,268.628,275.63,280.13,282.632,286.628,289.13,293.63,295.88,296.96,301.46,304.457,306.707,307.796,313.295,319.298,322.295,326.795,331.295,335.795,338.045,340.295,341.384,346.388,352.886,358.889,361.139,362.228,365.225,371.723,373.973,375.062,379.562,382.559,389.057,394.556,396.806,397.895,400.892,405.896,410.9,415.4,421.898,427.901,430.898,433.148,434.237,437.234,441.401,445.901,448.898,451.148,452.237,456.233,460.733,465.233,467.483,468.572,473.072,481.568,488.066,492.566,494.816,495.905,498.902,503.906,508.91,513.914,518.414,524.417,526.919,532.418,538.421,541.418,545.918,550.418,554.918" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.25,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.33,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.78,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.67,0.33,0.5,0.5,0.5,0.25,0.25,0.55,0.56,0.72,0.67,0.25,0.55,0.33,0.72,0.25,0.55,0.5,0.33,0.72,0.61,0.25,0.55,0.33,0.56,0.56,0.5,0.72,0.67,0.33,0.25,0.55,0.33,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.94,0.72,0.5,0.25,0.55,0.33,0.56,0.56,0.56,0.5,0.67,0.28,0.61,0.67,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and grey: the 7-oxabicyclo[2.2.1]heptane-2,3-dicarbonyl moiety of LB-100. PDB ID 2IAE (PP2AC) [11] and 5WG8 (PPP5C:LB-100 </text>
  </g>
  <g begin="text">
   <text y="713.855" x="58.1,62.096,66.596,73.598,78.098,80.6,84.596,89.096,92.093,94.343,97.34,101.84,104.837" svgx:width="0.44,0.5,0.78,0.5,0.28,0.44,0.5,0.33,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">complex) [2].</text>
  </g>
 </g>
</svg>
